Skip to content

José Manuel García-montes

3 papers in the library · 10 citations · publishing 2020-2025

Papers

Sort Most recent Most cited

Treatment-resistant depression and intranasal esketamine: Spanish clinical consensus on practical aspects

The European Journal of Psychiatry May 2, 2025 Josep Antoni Ramos‐quiroga, Fernando Mora, Silvia Arostegui et al. 4 citations

Pharmacological management of major depressive disorder has traditionally relied on antidepressants targeting the monoaminergic pathway. Treatment-resistant depression (TRD) patients have been frequently excluded from registrational trials, resulting in a lack of clear clinical recommendations for an optimised management. In recent years, treatments based on other mechanisms of action have been...

Mindfulness improves negative psychotic symptoms through reducing emotional and social withdrawal.

World Journal of Psychiatry April 19, 2025 Carmen Borrás-sansaloni, Marina Ricco-Pérez, Antoni Mayol et al. 1 citation

Psychotic disorders are characterized by both positive symptoms (hallucinations, delusions) and negative symptoms (emotional blunting, anhedonia) that impair daily functioning. While antipsychotic drugs and psychological interventions are effective when addressing positive symptoms, treatment of negative symptoms remains an ongoing challenge. Mindfulness-based interventions (MBIs) have been...

Ecstasy (MDMA): A rebellion coherent with the system.

Nordisk Alkohol Nark November 28, 2020 José Manuel García-montes, Marino Pérez-Álvarez, Miguel Ángel Sánchez-Moya et al. 5 citations

Aim: This study attempts to demonstrate the relevance of the socio-cultural model of drugs in explaining the impressive development of ecstasy in the last 45 years. Method: First the study describes the use of ecstasy by groups which have left their imprint on the substance: university students, gays, yuppies and the "New Age" movement. Then the link between ecstasy and techno music led to the...